CD4 and bladder transitional cell carcinoma: For instance, Fong and colleagues used scRNA-seq and T cell receptor (TCR) sequencing to uncover distinct cytotoxic CD4+ T cell subtypes within the BLCA TME, highlighting the pivotal role of the unique gene signature of cytotoxic CD4+ T cell in predicting the effectiveness of immunotherapy (12).